Modulation of serine/threonine-protein phosphatase 1 (PP1) complexes: A promising approach in cancer treatment

Bárbara Matos, John Howl, Carmen Jerónimo, Margarida Fardilha*

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    9 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)2680-2698
    Number of pages19
    JournalDrug Discovery Today
    Volume26
    Issue number11
    DOIs
    Publication statusPublished (VoR) - Nov 2021

    Funding

    We thank the Portuguese Foundation for Science and Technology (FCT) and the European Union (QREN, FEDER and COMPETE frameworks) for funding both iBiMED (UID/BIM/04501/2020, POCI-01-0145-FEDER-007628 and UID/BIM/04501/2019, respectively) and an individual scholarship for BM (SFRH/BD/146032/2019).

    FundersFunder number
    QRENUID/BIM/04501/2019, POCI-01-0145-FEDER-007628, SFRH/BD/146032/2019, UID/BIM/04501/2020
    European Commission
    Fundação para a Ciência e a Tecnologia

      Keywords

      • Cancer treatment
      • Peptides
      • PP1 complexes
      • Small molecules

      Fingerprint

      Dive into the research topics of 'Modulation of serine/threonine-protein phosphatase 1 (PP1) complexes: A promising approach in cancer treatment'. Together they form a unique fingerprint.

      Cite this